Correlation Between Nanologix and Viking Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Nanologix and Viking Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nanologix and Viking Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nanologix and Viking Therapeutics, you can compare the effects of market volatilities on Nanologix and Viking Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nanologix with a short position of Viking Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nanologix and Viking Therapeutics.

Diversification Opportunities for Nanologix and Viking Therapeutics

-0.73
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Nanologix and Viking is -0.73. Overlapping area represents the amount of risk that can be diversified away by holding Nanologix and Viking Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Viking Therapeutics and Nanologix is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nanologix are associated (or correlated) with Viking Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Viking Therapeutics has no effect on the direction of Nanologix i.e., Nanologix and Viking Therapeutics go up and down completely randomly.

Pair Corralation between Nanologix and Viking Therapeutics

Given the investment horizon of 90 days Nanologix is expected to generate 37.23 times more return on investment than Viking Therapeutics. However, Nanologix is 37.23 times more volatile than Viking Therapeutics. It trades about 0.16 of its potential returns per unit of risk. Viking Therapeutics is currently generating about -0.23 per unit of risk. If you would invest  0.00  in Nanologix on October 11, 2024 and sell it today you would earn a total of  0.01  from holding Nanologix or generate 9.223372036854776E16% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Nanologix  vs.  Viking Therapeutics

 Performance 
       Timeline  
Nanologix 

Risk-Adjusted Performance

10 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Nanologix are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. In spite of fairly conflicting essential indicators, Nanologix showed solid returns over the last few months and may actually be approaching a breakup point.
Viking Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Viking Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Nanologix and Viking Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Nanologix and Viking Therapeutics

The main advantage of trading using opposite Nanologix and Viking Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nanologix position performs unexpectedly, Viking Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Viking Therapeutics will offset losses from the drop in Viking Therapeutics' long position.
The idea behind Nanologix and Viking Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Stocks Directory
Find actively traded stocks across global markets